Instil Bio, Inc. ( TIL) - Stock Earnings
TIL Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 12, 2026, midnight | — / — | — | — / — | — |
TIL Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -13.6 million USD | — USD |
| 2025Q4 | -8.2 million USD | — USD |
| 2026Q1 | -4.2 million USD | — USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
TIL Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -156.1 million USD | — USD |
| 2024 | -74.1 million USD | — USD |
| 2025 | -71.4 million USD | — USD |
| 2026 Est. | — | — |
TIL
Price: $7.13
52 week price:
Earnings Per Share: -10.70 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 566200
Ebitda: -268970Market Capitalization: 52.4 million